Sanofi gets se­ri­ous in Chi­na with plans to hire 300 for $76M R&D site in Cheng­du

Sev­er­al big phar­mas have re­cent­ly shut­tered their re­search op­er­a­tions in Chi­na, but Sanofi is ap­par­ent­ly buck­ling down in the re­gion with a new glob­al R&D hub. The com­pa­ny is hir­ing 300 peo­ple in Cheng­du, Chi­na to run a tech-fo­cused op­er­a­tion that’s meant to speed up analy­sis of its clin­i­cal tri­als.

Sanofi is in­vest­ing €66 mil­lion ($76.6 mil­lion) in the hub and will have it ful­ly staffed by 2020. The R&D cen­ter is sup­posed to sup­port Sanofi’s drug de­vel­op­ment by man­ag­ing glob­al mul­ti-cen­ter clin­i­cal tri­al da­ta and files. The com­pa­ny says it will “take ad­van­tage of lo­cal tal­ents” to strength­en Sanofi’s dig­i­tal ca­pa­bil­i­ties, speed­ing up tri­als re­sults.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.